| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |